This website uses cookies to enhance the user experience.
A

AQUA BIO TECHNOLOGY ASA886 582 412

Research
Public limited company
c/o Aqua Bio Technology ASA Bygdøy allé 3 0257 OSLO, Norge

AQUA BIO TECHNOLOGY ASA

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Links

Organization

Chairman of the board
Years since formation
20 years
since Mar 9, 2004
Type
Public limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
47,416,297
1 share class
Total number of shareholders
3019
129 companies, 2,890 persons
Belongs to group of

Financials

Total operating income 2023
516,293
NOK
Annual total result 2023
-36,889,095
NOK
Total equity 2023
62,722,660
NOK
Last update: Nov 21, 2024

Management

Management / administration

NameRoleShares
Managing Director/CEO-

Board

NameRoleShares
Chairman-
Board Member-
Board Member-
Board Member-
Board Member-
Board Member-
Board Member-
Observer-

Others

NameRoleShares
R
RSM NORGE AS
Auditor-
T
TOPCONSULT AS
Accountant-

Top 10 individual shareholders

NameRoleShares
-
19.34 %
directly 0.15 %
indirectly 19.19 %
-
5.36 %
indirectly
-
4.37 %
directly 1.49 %
indirectly 2.88 %
-
3.26 %
directly 0.65 %
indirectly 2.61 %
-
2.7 %
indirectly
-
2.42 %
directly 0.07 %
indirectly 2.35 %
-
2.35 %
indirectly
-
2.29 %
indirectly
-
2.12 %
indirectly
-
2.12 %
directly
Last update: Dec 11, 2024

Ownership

Company shareholders

NameShare classNumber of sharesShare
R
RH INDUSTRI AS
NO0010307135
8,787,927
18.53 %
X
XQS HOLDING AS
NO0010307135
3,481,265
7.34 %
NO0010307135
3,216,628
6.78 %
D
DIRIGENT AS
NO0010307135
3,063,342
6.46 %
NO0010307135
2,894,761
6.1 %
V
VIDDAS AS
NO0010307135
1,366,158
2.88 %
B
BLIXEN INVEST AS
NO0010307135
1,280,793
2.7 %
K
KJEVEORTOPED ESPEN DAHL AS
NO0010307135
1,239,105
2.61 %
H
HABU INVEST AS
NO0010307135
1,004,000
2.12 %
NO0010307135
1,003,528
2.12 %
NO0010307135
964,882
2.03 %
S
SKINTEAM INVEST AS
NO0010307135
771,939
1.63 %
NO0010307135
771,939
1.63 %
P
PLATINA SEAFOOD AS
NO0010307135
733,332
1.55 %
F
FACE2FACE HOLDING AS
NO0010307135
716,842
1.51 %
NO0010307135
707,787
1.49 %
A
AKVAKULTURPARTNER AS
NO0010307135
609,004
1.28 %
I
ICE CAPITAL AS
NO0010307135
604,680
1.28 %
M
MAMIMA AS
NO0010307135
550,000
1.16 %
NO0010307135
540,364
1.14 %
H
HAAV HOLDING AS
NO0010307135
415,000
0.88 %
K
KNUT FOSSE AS
NO0010307135
400,003
0.84 %
NO0010307135
400,000
0.84 %
B
BARDAF AIR AS
NO0010307135
400,000
0.84 %
U
UNIVERSAL EXPORTS AS
NO0010307135
370,172
0.78 %
W
WORLD HERITAGE SALMON AS
NO0010307135
366,666
0.77 %
NO0010307135
350,000
0.74 %
NO0010307135
323,775
0.68 %
NO0010307135
316,500
0.67 %
NO0010307135
308,569
0.65 %
V
VARMING HOLDING AS
NO0010307135
267,769
0.56 %
P
PLAN INVESTOR AS
NO0010307135
243,499
0.51 %
NO0010307135
242,476
0.51 %
A
AS BOLAKS
NO0010307135
241,617
0.51 %
F
FIMA AS
NO0010307135
233,332
0.49 %
A
ASINVEST AS
NO0010307135
232,713
0.49 %
L
LFC AS
NO0010307135
201,639
0.43 %
NO0010307135
200,067
0.42 %
N
NORDNET LIVSFORSIKRING AS
NO0010307135
186,995
0.39 %
I
IKURA INVEST AS
NO0010307135
183,332
0.39 %
NO0010307135
183,265
0.39 %
NO0010307135
176,935
0.37 %
NO0010307135
154,387
0.33 %
NO0010307135
150,000
0.32 %
NO0010307135
150,000
0.32 %
NO0010307135
146,666
0.31 %
A
AARSETH AS
NO0010307135
139,818
0.29 %
NO0010307135
124,894
0.26 %
T
TANNLEGE PER HAGEN AS
NO0010307135
106,866
0.23 %
NO0010307135
104,500
0.22 %
NO0010307135
100,000
0.21 %
NO0010307135
95,000
0.2 %
NO0010307135
94,582
0.2 %
NO0010307135
94,045
0.2 %
NO0010307135
93,090
0.2 %
NO0010307135
84,000
0.18 %
B
BOHAN & CO AS
NO0010307135
75,023
0.16 %
NO0010307135
74,000
0.16 %
B
BOMMEGRINDA AS
NO0010307135
71,429
0.15 %
NO0010307135
70,833
0.15 %
D
DEZOMAQ HOLDING AS
NO0010307135
70,000
0.15 %
NO0010307135
62,033
0.13 %
NO0010307135
61,500
0.13 %
V
VECTOR FINANCIAL SYSTEMS AS
NO0010307135
60,000
0.13 %
NO0010307135
60,000
0.13 %
NO0010307135
59,398
0.13 %
NO0010307135
55,731
0.12 %
NO0010307135
53,800
0.11 %
S
SUNN PROSJEKT AS
NO0010307135
51,000
0.11 %
NO0010307135
50,446
0.11 %
NO0010307135
50,034
0.11 %
NO0010307135
50,000
0.11 %
V
VIKASTØL INVEST AS
NO0010307135
49,358
0.1 %
NO0010307135
48,022
0.1 %
A
A-ZYM AS
NO0010307135
46,500
0.1 %
R
ROM INVESTOR AS
NO0010307135
46,308
0.1 %
NO0010307135
45,747
0.1 %
K
KROGSRUD INVEST AS
NO0010307135
45,039
0.09 %
P
POLAR BULL AS
NO0010307135
42,201
0.09 %
NO0010307135
41,377
0.09 %
NO0010307135
40,000
0.08 %
NO0010307135
40,000
0.08 %
NO0010307135
40,000
0.08 %
NO0010307135
38,881
0.08 %
NO0010307135
38,663
0.08 %
TH
NO0010307135
37,649
0.08 %
NO0010307135
35,714
0.08 %
NO0010307135
35,300
0.07 %
NO0010307135
35,195
0.07 %
NO0010307135
33,351
0.07 %
NO0010307135
32,570
0.07 %
NO0010307135
30,798
0.06 %
NO0010307135
30,000
0.06 %
NO0010307135
29,598
0.06 %
NO0010307135
28,468
0.06 %
A
AKTIV PORTFOLIO AS
NO0010307135
27,640
0.06 %
NO0010307135
27,048
0.06 %
S
SEBEL INVEST AS
NO0010307135
25,050
0.05 %
NO0010307135
25,000
0.05 %
NO0010307135
25,000
0.05 %

Shares owned by the AQUA BIO TECHNOLOGY ASA

NameShare classNumber of sharesShare
C
COSMED BEAUTY AS
Ordinary shares
300
100 %
S
SKINTEAM NORGE AS
Ordinary shares
933,279
100 %
K
KILDA BIOLINK AS
Ordinary shares
1,000
100 %
C
COVER BRANDS AS
Ordinary shares
13,800,000
100 %
A
AQUA BIO TECHNOLOGY ASA
NO0010307135
12,780
0.03 %
Last update: May 24, 2024

Group structure

Financials

in NOK

Summary

Year202320222021
Total operating income
516,293
941,747
1,975,588
Annual Total Result
-36,889,095
-25,432,923
-19,602,941
Total assets
99,622,226
56,437,964
34,161,500
Total liabilities
36,899,566
61,764,994
15,945,280
Total equity
62,722,660
-5,327,030
18,216,220

P&L

Year202320222021
Total operating income
516,293
941,747
1,975,588
Total operating costs
22,779,203
23,233,376
20,322,933
Operating result
-22,262,910
-22,291,629
-18,347,345
Financial income/costs
-14,786,876
-3,497,034
-1,255,596
Profit before tax
-37,049,786
-25,788,663
-19,602,941
Total tax & extraordinary income/cost
-160,691
-355,740
0
Annual Total Result
-36,889,095
-25,432,923
-19,602,941

Balance overview

Year202320222021
Total fixed assets
91,712,855
48,567,656
12,303,167
Total current assets
7,909,371
7,870,308
21,858,333
Total assets
99,622,226
56,437,964
34,161,500
Short term debt
36,046,449
21,998,069
12,279,842
Long term debt
853,117
39,766,925
3,665,438
Total liabilities
36,899,566
61,764,994
15,945,280
Contributed capital
164,326,415
51,652,530
51,527,530
Retained earnings
-101,603,755
-56,979,560
-33,311,310
Total equity
62,722,660
-5,327,030
18,216,220
Total equity and liabilities
99,622,226
56,437,964
34,161,500

Classification

Category
Type of organization
Public limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
M
Main industrial area
Professional, scientific and technical activities
72
Activity
Scientific research and development
72.1
Main industrial group
Research and experimental development on natural sciences and engineering
72.11
Industrial group
Research and experimental development on biotechnology
72.110
Industrial group
Research and experimental development on biotechnology